Sunday, 2 Nov 2025
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA
logo logo
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
  • 🔥
  • Trump
  • VIDEO
  • House
  • White
  • ScienceAlert
  • Trumps
  • Watch
  • man
  • Health
  • Season
Font ResizerAa
American FocusAmerican Focus
Search
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
Follow US
© 2024 americanfocus.online – All Rights Reserved.
American Focus > Blog > Economy > Investors react to Trump’s massive increase in China tariffs​
Economy

Investors react to Trump’s massive increase in China tariffs​

Last updated: October 12, 2025 3:12 pm
Share
Investors react to Trump’s massive increase in China tariffs​
SHARE

NEW YORK (Reuters) – On Friday, U.S. President Donald Trump announced an escalation in economic tensions with China by raising tariffs on imports from China to 100%. He also revealed his intention to implement export controls on “any and all critical software,” citing China’s recent restrictions on exporting rare earth minerals vital for technology and other manufacturing sectors as a motivating factor.

Earlier statements indicated that he sees no necessity for a scheduled meeting with President Xi Jinping in two weeks, contributing to a decline in the value of the dollar, U.S. stock prices, and prompting investors to seek refuge in safe-haven assets like Treasuries.

This week, China imposed stricter controls on the export of essential rare earth materials and additionally announced that starting October 14, U.S. ships would incur additional port fees.

COMMENTS:

BRIAN JACOBSEN, CHIEF ECONOMIST, ANNEX WEALTH MANAGEMENT, MENOMONEE FALLS, WISCONSIN:

“Here we go again. Engaging in trade negotiations via social media can cause significant disruptions in the markets, but circumstances can evolve rapidly. By establishing a November 1st date for tariff implementation, there is ample time for discussions to occur rather than merely exchanging press statements. The threats to economic growth and inflation risks are elevated compared to just 12 hours ago, yet these risks are not necessarily inevitable.”

CLAYTON TRIICK, HEAD OF PORTFOLIO MANAGEMENT FOR PUBLIC STRATEGIES AT ANGEL OAK CAPITAL, ATLANTA:

“It seems a bit premature to consider this a significant bubble. Volatility has remained quite low due to the government shutdown and lack of data, and I believe volatility should be more pronounced. This situation needed a catalyst, and it appears this is the trigger for a repricing of values.”

See also  Best money market account rates today, July 21, 2025 (Earn up to 4.41% APY)

“Concerns around labor and inflation persist, and given the absence of volatility and the automatic purchasing of equities last week, I anticipated that if there was clarity around the government reopening in the U.S. today, it might result in a sell-off triggered by newfound data influx and market awakening. However, we received the headline on Trump’s stance early on regarding China.

“I think this volatility was necessary. I wouldn’t characterize it as the onset of a major sell-off. There’s still a considerable amount of cash available to invest in the market, so I doubt we would see sustained downward movements. However, I wouldn’t be surprised if equities traded sideways for some time; I don’t foresee a significant rally at the moment.”

ANSHUL SHARMA, CHIEF INVESTMENT OFFICER, SAVVY WEALTH, NEW YORK:

“Today’s drastic market downturn highlights renewed anxiety over escalating trade conflicts between the U.S. and China, especially in light of the potential substantial tariff increase and the recent cancellation of the meeting with President Xi. These actions introduce considerable risk to global supply chains, corporate profit margins, and investor confidence.”

TAGGED:ChinaIncreaseinvestorsMassivereactTariffsTrumps
Share This Article
Twitter Email Copy Link Print
Previous Article Trump Has To Flee The Country To Find Someone Who Will Applaud Him
Next Article Hempstead Town officials ‘secretly’ plotted to appoint new supervisor, flouting the law, judge rules Hempstead Town officials ‘secretly’ plotted to appoint new supervisor, flouting the law, judge rules
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Popular Posts

Playwright David Mamet Hurls EPIC Insult at CNN’s Jake Tapper Over Biden Decline Hypocrisy (VIDEO) |

David Mamet, the celebrated American playwright who has recently emerged as a prominent conservative voice,…

June 14, 2025

Jill & Joe Refuse to Look at Kamala Harris at Kennedy Center Honors

Joe Biden and Jill Biden's awkward interaction with Kamala Harris at a recent event has…

December 9, 2024

TACO vs. the Game-Theoretic Art of the Deal

It’s clear that President Trump’s response to the “TACO” (“Trump Always Chickens Out”) moniker isn’t…

June 3, 2025

Expert Tips to Look Your Best for Any Occasion

Planning for a big event can be both exciting and nerve-wracking. We all want to…

March 19, 2025

Powell may have a hard time avoiding Trump’s ‘Too Late’ label even as Fed chief does the right thing

President Donald Trump has recently given Federal Reserve Chair Jerome Powell a new nickname, "Too…

May 10, 2025

You Might Also Like

Is T-Mobile US (TMUS) One of the Best Beaten Down Growth Stocks to Buy?
Economy

Is T-Mobile US (TMUS) One of the Best Beaten Down Growth Stocks to Buy?

November 2, 2025
Morgan Stanley Turns More Bullish on Microsoft (MSFT) After Earnings Beat
Economy

Morgan Stanley Turns More Bullish on Microsoft (MSFT) After Earnings Beat

November 1, 2025
Corn Heads on the Higher Side of Unchanged to Close Out October
Economy

Corn Heads on the Higher Side of Unchanged to Close Out October

November 1, 2025
Pfizer sues Metsera, Novo Nordisk over rival obesity drug bid
Economy

Pfizer sues Metsera, Novo Nordisk over rival obesity drug bid

November 1, 2025
logo logo
Facebook Twitter Youtube

About US


Explore global affairs, political insights, and linguistic origins. Stay informed with our comprehensive coverage of world news, politics, and Lifestyle.

Top Categories
  • Crime
  • Environment
  • Sports
  • Tech and Science
Usefull Links
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA

© 2024 americanfocus.online –  All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?